Literature DB >> 24788897

Molecular analysis in X-linked adrenoleukodystrophy patients: identification of a novel mutation.

Asude Durmaz1, Tahir Atik, Hüseyin Onay, Ebru Erbaş Canda, Sema Kalkan Uçar, Fikret Bademkıran, Mahmut Coker, Özgür Coğulu, Ferda Özkınay.   

Abstract

X linked adrenoleukodystrophy (X-ALD) is a neurodegenerative disease characterized by progressive demyelination of the central nervous system, adrenocortical insufficiency and elevated levels of very long chain fatty acids (VLCFAs). It is caused by mutations in ABCD1 gene located at Xq28. More than 1,300 mutations have been identified to date which is unique to each patient. In this study we report the mutational analysis of 2 X-ALD patients (1 male and 1 female) showing variable clinical spectrum. The mutation analysis of the female patient revealed IVS5-6delC (c.1489-6delC) and p. P543L variations in compound heterozygous state. The male patient was found to be hemizygous for a novel mutation, p. R104P. In conclusion, while defining a novel mutation, the cases presented herein may contribute to the mutation and clinical spectrum of X-ALD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24788897     DOI: 10.1007/s11011-014-9552-1

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  15 in total

1.  Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening.

Authors:  L Bezman; A B Moser; G V Raymond; P Rinaldo; P A Watkins; K D Smith; N E Kass; H W Moser
Journal:  Ann Neurol       Date:  2001-04       Impact factor: 10.422

2.  Mutational analyses of Taiwanese kindred with X-linked adrenoleukodystrophy.

Authors:  Hou-Chang Chiu; Jao-Shwann Liang; Jinn-Shyan Wang; Jyh-Feng Lu
Journal:  Pediatr Neurol       Date:  2006-10       Impact factor: 3.372

3.  Adrenoleukodystrophy in Norway: high rate of de novo mutations and age-dependent penetrance.

Authors:  Morten A Horn; Lars Retterstøl; Michael Abdelnoor; Ola H Skjeldal; Chantal M E Tallaksen
Journal:  Pediatr Neurol       Date:  2013-03       Impact factor: 3.372

4.  Mutational analysis and genotype-phenotype correlation of 29 unrelated Japanese patients with X-linked adrenoleukodystrophy.

Authors:  H Takano; R Koike; O Onodera; R Sasaki; S Tsuji
Journal:  Arch Neurol       Date:  1999-03

5.  X-linked adrenoleukodystrophy in women: a cross-sectional cohort study.

Authors:  Marc Engelen; Mathieu Barbier; Inge M E Dijkstra; Remmelt Schür; Rob M A de Bie; Camiel Verhamme; Marcel G W Dijkgraaf; Patrick A Aubourg; Ronald J A Wanders; Bjorn M van Geel; Marianne de Visser; Bwee T Poll-The; Stephan Kemp
Journal:  Brain       Date:  2014-01-29       Impact factor: 13.501

6.  A method and server for predicting damaging missense mutations.

Authors:  Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev
Journal:  Nat Methods       Date:  2010-04       Impact factor: 28.547

7.  Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters.

Authors:  J Mosser; A M Douar; C O Sarde; P Kioschis; R Feil; H Moser; A M Poustka; J L Mandel; P Aubourg
Journal:  Nature       Date:  1993-02-25       Impact factor: 49.962

8.  Cerebral X-linked adrenoleukodystrophy in a girl with Xq27-Ter deletion.

Authors:  Eli Hershkovitz; Ginat Narkis; Zamir Shorer; Ann B Moser; Paul A Watkins; Hugo W Moser; Esther Manor
Journal:  Ann Neurol       Date:  2002-08       Impact factor: 10.422

Review 9.  X-linked adrenoleukodystrophy.

Authors:  Hugo W Moser; Asif Mahmood; Gerald V Raymond
Journal:  Nat Clin Pract Neurol       Date:  2007-03

10.  Mutations, clinical findings and survival estimates in South American patients with X-linked adrenoleukodystrophy.

Authors:  Fernanda dos Santos Pereira; Ursula Matte; Clarissa Troller Habekost; Raphael Machado de Castilhos; Antonette Souto El Husny; Charles Marques Lourenço; Angela M Vianna-Morgante; Liane Giuliani; Marcial Francis Galera; Rachel Honjo; Chong Ae Kim; Juan Politei; Carmen Regla Vargas; Laura Bannach Jardim
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.